Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2025-12-25 @ 3:15 PM
Study NCT ID:
NCT04150068
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-26
First Post:
2019-10-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-21
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-10-28
First Submit QC Date:
None
Study First Post Date:
2019-11-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-09-28
Results First Submit QC Date:
None
Results First Post Date:
2021-10-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-25
Last Update Post Date:
2025-09-26
Last Update Post Date Type:
ESTIMATED